Skip to main content
SpringerLink
Log in

Clinical Usefulness of 5-FU Metabolic Enzymes as Predictive Markers of Response to Chemotherapy in Colorectal Cancer

  • Letter to the Editor
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Shigeta K, Ishii Y, Hasegawa H, Okabayashi K, Kitagawa Y (2014) Evaluation of 5-fluorouracil metabolic enzymes as predictors of response to adjuvant chemotherapy outcomes in patients with stage II/III colorectal cancer: a decision-curve analysis. World J Surg 38(12):3248–3256. doi:10.1007/s00268-014-2738-1

    Article  PubMed  Google Scholar 

  2. Boni V, Bitarte N, Cristobal I, Zarate R, Rodriguez J, Maiello E et al (2010) miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol Cancer Ther 9(8):2265–2275. doi:10.1158/1535-7163.MCT-10-0061

    Article  CAS  PubMed  Google Scholar 

  3. Deng J, Lei W, Fu JC, Zhang L, Li JH, Xiong JP (2014) Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro. Biochem Biophys Res Commun 443(3):789–795. doi:10.1016/j.bbrc.2013.11.064

    Article  CAS  PubMed  Google Scholar 

  4. Caramés C, Cristóbal I, Moreno V, Del Puerto L, Moreno I, Rodriguez M et al (2015) MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer. Int J Colorectal Dis 30(7):899–906. doi:10.1007/s00384-015-2231-9

    Article  PubMed  Google Scholar 

  5. Soong R, Shah N, Salto-Tellez M, Tai BC, Soo RA, Han HC et al (2008) Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy. Ann Oncol 19(5):915–919

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

PI12/01552 and PI13/02609 Grants from “Instituto de Salud Carlos III FEDER” and S2010/BMD2344, PT13/0010/0012 and RD12/0036/0051. R. Manso and P. González-Alonso are supported by “Fundación Conchita Rábago de Jiménez Díaz”.

Author information

Authors and Affiliations

  1. Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital “Fundacion Jimenez Diaz”, Avda. Reyes Católicos-2, 28040, Madrid, Spain

    Ion Cristóbal & Jesús García-Foncillas

  2. Pathology Department, IIS-Fundacion Jimenez Diaz-UAM, University Hospital “Fundacion Jimenez Diaz”, 28040, Madrid, Spain

    Rebeca Manso, Paula González-Alonso, Juan Madoz-Gurpide & Federico Rojo

Authors
  1. Ion Cristóbal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rebeca Manso
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paula González-Alonso
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Juan Madoz-Gurpide
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Federico Rojo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jesús García-Foncillas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Ion Cristóbal or Jesús García-Foncillas.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cristóbal, I., Manso, R., González-Alonso, P. et al. Clinical Usefulness of 5-FU Metabolic Enzymes as Predictive Markers of Response to Chemotherapy in Colorectal Cancer. World J Surg 40, 1017–1018 (2016). https://doi.org/10.1007/s00268-015-3176-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-015-3176-4

Keywords

Search

Navigation